By Karen Deyo, Director of Investor Research, Israel BD, LSN

Digital Redefining Early Stage Investments (RESI), June 8-10, is fast-approaching and early bird rates end tomorrow! Sign up by Friday, May 5 to save $50 on registration to take advantage of the RESI partnering system which enables early-stage fundraising executives to connect with investors and strategic partners that are a fit for their product and stage of development.

Digital RESI stands apart from other virtual partnering conferences in many ways, including its content and resources, but most importantly, its partnering platform. The RESI partnering platform is a user-friendly system designed to take out the guesswork so investors, strategic partners, and fundraising entrepreneurs can easily find and book meetings with those that are a best fit based on sector, indication, product, development phase, and more.

The Digital RESI partnering platform opens May 17, providing registered attendees three weeks to set up their company profiles and start searching for potential partners and book meetings to optimize their time during the conference. Prior to the launch of partnering, Life Science Nation (LSN) highlights several free tutorials and webinars instructing how to use the platform efficiently, as well as tips on how to stand out when requesting meetings.

Click the date(s) below to register for the FREE Strategies for Successful Partnering workshops:

• May 11 (EU & Israel)
• May 19 (Global)
• June 2 (Global)

Check out more free partnering resources from LSN:

• Getting it Right from Pitch to Partner
• Before Buying a Ticket to a Digital Partnering Event – Know You Have a Shot
• Get Ready for Successful Partnering
• How to Fill Your Day with Meetings
• The Importance of Partnering in the Life Sciences

By Gregory Mannix, Vice President International Business Development, General Manager Europe, LSN

It is hard to believe, but even during these challenging times, funding and deal-making in the life sciences has not slowed down, and in some sectors, has accelerated. Life Science Nation (LSN) has contributed to this momentum by providing a digital venue for the different players to connect and build relationships to move the needle.

LSN sees that Tech Hubs—incubators, accelerators, life science clusters, etc.—from around the world are making a huge difference in preparing entrepreneurs for success in their projects and have seen a fantastic opportunity to collaborate closely with these groups and their constituent companies. It’s a win-win-win. By facilitating access to resources, including the Investor Database, Redefining Early Stage Investments (RESI) conference series, Innovator’s Pitch Challenge, and industry expertise, LSN is helping entrepreneurs meet the investors and strategic partners they need to meet and save money at the same time.

LSN is currently offering two programs to accelerate Tech Hub involvement and help constituents get funded:

1. 50% discount on any RESI conference registration for early-stage constituent companies from participating Tech Hubs
2. Group Fundraising Package ($1,500 per company) for Tech Hubs including:
   1. 3-month access to the Investor Database
   2. Registration at RESI
   3. Participation in the Innovator’s Pitch Challenge

If your Tech Hub is looking for ways to add value to fundraising constituents, connect with the LSN business development team to see which offerings best fit your needs and the companies in your community. LSN shares the mission of global Tech Hubs in seeing promising technologies advance from the lab to the clinic, and into the hands of providers and their patients.

Want to learn more? The business development team at Life Science Nation is available to answer questions and share additional details to help you meet your partnership goals!
International & MA (USA)	West Coast (USA)	East Coast (USA)	Midwest (USA) & Canada
Greg Mannix Vice President International Business Development Schedule a call with me!	Candice He  Global Investment Strategist Schedule a call with me!	Ashley Zborowski Director of Business Development Schedule a call with me!	Elizabeth Murphy Manager of Business Development Schedule a call with me!

By Ashley Zborowski, Director of Business Development, LSN

The Redefining Early Stage Investment (RESI) Service Provider Showcase helps companies gain unprecedented visibility into the early-stage life science community and leverages Life Science Nation (LSN)’s close-knit network of key decision-makers to make promising connections with future clients.  Service providers are an important asset in the fundraising ecosystem, and this new program is designed to increase their exposure to the RESI community.

Digital RESI, June 8-10, proudly features service providers advancing early-stage startups within drugs, devices, diagnostics, and digital health. Often the unsung heroes of fundraising startups, these powerful partnerships are essential in commercializing, building teams, conducting research, manufacturing, and so much more! Meet and get to know some featured service providers at Digital RESI June, and contact us to learn more about this special offer.

MERIT

MERIT is an innovative specialty CRO providing clinical trial data collection and interpretation in the ophthalmology and respiratory disciplines. Our portfolio of solutions offers deep clinical expertise, unique technology, and exceptional service for our partners, sponsors, and CROs.

PharmaDirections

At PharmaDirections, gain access to top talent without the cost or risk of a full-time, in-house team. More than just a consultant or outside vendor, we are an extension of your team and are accountable for all aspects of a project, from discovery to regulatory approval.

SPH Phililab

SPH Phililab an innovation pharmaceutical company that develop, registrar, and manufacture generic and modified new drug product in USA and China. Our product portfolio focuses on the two largest pharmaceutical markets in the world, plus our unique background of management team and scientists made us a pioneer as an international player in the pharmaceutical industry.